Display options
Cite
Harkin M, Miller J, Lim SY, et al. "Reply: Conversion From Continuous Infusion Fentanyl to Hydromorphone in the Pediatric Intensive Care Unit". Ann Pharmacother. 2021;10600280211028672doi: 10.1177/10600280211028672.
Harkin, M., Miller, J., Lim, S. Y., Neely, S., Walsh, C., & Johnson, P. N. (2021). "Reply: Conversion From Continuous Infusion Fentanyl to Hydromorphone in the Pediatric Intensive Care Unit". The Annals of pharmacotherapy, 10600280211028672. https://doi.org/10.1177/10600280211028672
Harkin, Maura, et al. ""Reply: Conversion From Continuous Infusion Fentanyl to Hydromorphone in the Pediatric Intensive Care Unit"." The Annals of pharmacotherapy vol. (2021): 10600280211028672. doi: https://doi.org/10.1177/10600280211028672
Harkin M, Miller J, Lim SY, Neely S, Walsh C, Johnson PN. "Reply: Conversion From Continuous Infusion Fentanyl to Hydromorphone in the Pediatric Intensive Care Unit". Ann Pharmacother. 2021 Jun 24;10600280211028672. doi: 10.1177/10600280211028672. Epub 2021 Jun 24. PMID: 34165365.
Copy Download .nbib Format: NLM
Share it on

Ann Pharmacother. 2021 Jun 24;10600280211028672. doi: 10.1177/10600280211028672. Epub 2021 Jun 24.

"Reply: Conversion From Continuous Infusion Fentanyl to Hydromorphone in the Pediatric Intensive Care Unit".

The Annals of pharmacotherapy

Maura Harkin, Jamie Miller, Sin Yin Lim, Stephen Neely, Christina Walsh, Peter N Johnson

Affiliations

  1. Oklahoma Children's Hospital, Oklahoma City, OK, USA.
  2. University of Oklahoma College of Pharmacy, Oklahoma City, OK, USA.
  3. University of Wisconsin, Madison, WI, USA.
  4. University of Oklahoma College of Medicine, Oklahoma City, OK, USA.

PMID: 34165365 DOI: 10.1177/10600280211028672

[No abstract available.]

Publication Types